The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2007
DOI: 10.1254/jphs.fp0061565
|View full text |Cite
|
Sign up to set email alerts
|

The Seed Extract of Cassia obtusifolia Ameliorates Learning and Memory Impairments Induced by Scopolamine or Transient Cerebral Hypoperfusion in Mice

Abstract: Abstract. In the present study, we assessed the effect of the ethanolic extract of the seeds of Cassia obtusifolia (COE) on the learning and memory impairments induced by scopolamine or transient bilateral common carotid artery occlusion (2VO). In a study of the cholinergic dysfunction induced by scopolamine, single COE (25, 50, or 100 mg / kg, p.o.) administration significantly attenuated scopolamine-induced cognitive impairments as determined by the passive avoidance and Y-maze tasks (P<0.05) and also reduce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
64
0
2

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 106 publications
(67 citation statements)
references
References 51 publications
1
64
0
2
Order By: Relevance
“…Cholinergic agents include ACh precursors, which increase the synthesis of ACh; nicotinic or M1 muscarinic agonists, which directly stimulate cholinergic receptors or allosterically modulate nAChR [41] ; and synaptic AChE inhibitors, which prevent the degradation of ACh. Recent preclinical and clinical evidence indicates that treatment with cholinergic agents has beneficial effects on dementia of vascular origin [42][43][44][45][46][47][48] .…”
Section: Cholinergic Deficiency In Vad Animal Models and Vad Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cholinergic agents include ACh precursors, which increase the synthesis of ACh; nicotinic or M1 muscarinic agonists, which directly stimulate cholinergic receptors or allosterically modulate nAChR [41] ; and synaptic AChE inhibitors, which prevent the degradation of ACh. Recent preclinical and clinical evidence indicates that treatment with cholinergic agents has beneficial effects on dementia of vascular origin [42][43][44][45][46][47][48] .…”
Section: Cholinergic Deficiency In Vad Animal Models and Vad Patientsmentioning
confidence: 99%
“…Methanesulfonyl fluoride (MSF), a highly selective CNS inhibitor of AChE, has recently been demonstrated to promote improvement in cognitive performance in patients with AD [124] , and it was also shown to attenuate simple learning and memory deficits in the MCAO rat model [16] . The seed extract of Cassia obtusifolia (COE), which has been found to inhibit AChE activity both in vitro and ex vivo, attenuated memory impairment induced by scopolamine or BCCAO in the passive-avoidance, Y-maze, and Morris water-maze tests in ICR mice [47] . Another agent that could increase ChAT activity and inhibit AChE activity is Z-Ligustilide (LIG).…”
Section: Other Ache Inhibitorsmentioning
confidence: 99%
“…The Morris water maze task was carried out as described elsewhere (Kim et al, 2007). On the following day, acquisition and retrieval session were conducted (Fig.…”
Section: Morris Water Maze Taskmentioning
confidence: 99%
“…In addition, a loss of forebrain cholinergic neurons, reduction in acetylcholine level in the cerebral cortex and hippocampus in Alzheimer's Disease. A defect in cholinergic transmission led to the development of acetylcholinesterase (AChE) inhibitors to treat dementia associated with Alzheimer's Disease 4 .…”
Section: Introductionmentioning
confidence: 99%